Business
TRxADE HEALTH Announces Proposed Public Offering of Common Stock
LUTZ, FL / ACCESSWIRE / August 23, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing
About this update from Scienture Holdings, Inc.
[{"type":"text","content":"LUTZ, FL / ACCESSWIRE / August 23, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) (\"TRxADE\" or the \"Company\"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced it has commenced an underwritten public offering.EF Hutton, division of Benchmark Investments, LLC, is acting as the sole book-running manager for the offering.The proposed offering of the common stock described above is being offered by the Company pursuant to a \"shelf\" registration statement on Form S-3 (File No. 333- 266432) filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on August 8, 2022, and the accompanying prospectus contained therein.The offering is being made only by means of a prospectus supplement and accompanying prospectus. A prospectus supplement describing the terms of the public offering will be filed with the SEC and will form a part of the effective registration statement.Copies of the prospectus supplement and the accompanying prospectus relating to this offering may be obtained, when available, on the SEC's website at http://www.sec.gov or by contacting EF Hutton, division of Benchmark Investments, LLC Attention: Syndicate Department, 590 Madison Avenue, 39th Floor, New York, NY 10022, by email at [email protected], or by telephone at (212) 404-7002.This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.About TRxADE HEALTH, Inc.TRxADE HEALTH, Inc. (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 13,815+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services and tele vet services. For more information on TRxADE Health, please visit the Company's IR website a...